Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by hk1966on Mar 21, 2022 5:33am
249 Views
Post# 34530507

RE:RE:Delay

RE:RE:Delay

Agreed and as always right on the money Smokey. Another factor which may be contributing to a delay is the nature of the company and its listing. Not only does Thrm have the stigma of being a penny stock but also a Canadian owned one at that. Herat me out on this peeps before the backlash.

there is a palpable anti Canadian sentiment in this US that has reared its ugly head in the aftermath of the Iraq invasion of 03 that has never really gone away. This festered under Obama with his distrust of Harper and ultimate trolling of him by canceling Keystone pipeline. Things certainly didn't improve under Trump with his noticeable disdain for our current PM: the constant threat of tariffs etc. Now under Biden there seems to be a benign (forgetful?) apathy of all things Canadian as it seems discussions about alternatives to Russian oil never include the most obvious source north of the border. 


Long diatribe above but my point is that I believe there is little chance the FDA approves this test owing to the fact that a small CDN company has pulled something off the some large US company hasn't. The bigwigs in DC would never hear of a CDN trumping a Pfizer, Abbot et all: they would rather ignore it even if it was the best thing since sliced bread.

at any rate I could be way off and we could have a submission followed by a quick approval as I seem to have been mostly wrong about this company to date so why stop now? GLTE. 
 

<< Previous
Bullboard Posts
Next >>